GENETIC POLYMORPHISMS AND CARDIOVASCULAR OUTCOMES IN CHINESE PATIENTS UNDERGOING PCI AND TREATED WITH CLOPIDOGREL AND ASPIRIN

Genetic polymorphisms of key proteins involved in clopidogrel absorption, metabolism, and action may contribute to variability in platelet inhibition in patients undergoing percutaneous coronary intervention (PCI), but their impacts on cardiovascular outcomes remain unclear. In this study, we